Advertisement
In germ cell tumors

TP53, MDM2 Alterations Linked to Cisplatin Resistance in GCT

0
TP53, MDM2 alterations predict adverse prognosis in patients with germ cell tumors
Exposure to phthalates and bisphenol A may impact circulating levels of total 25-hydroxyvitamin D

Exposure to Phthalates, BPA May Impact Total 25(OH)D in Adults

0
Metabolites of di(2-ethylhexyl) phthalate consistently inversely linked to total 25(OH)D
The thousands of miles of aging

Drug-Resistant Bacteria Live in America’s Water Systems

0
Bacteria found in plumbing may sicken thousands each year
For adults with acute Plasmodium vivax or P. falciparum

KAF156 Active for Adults With Vivax, Falciparum Malaria

0
Antimalarial activity seen with multiple and single dose, with no serious adverse events
Gonorrhea samples taken last spring from seven patients in Honolulu showed resistance to azithromycin at dramatically higher levels than typically seen in the United States

CDC: Higher Levels of Resistance Seen in Gonorrhea Treatment

0
First cluster of cases to show increased resistance to both azithromycin and ceftriaxone
An experimental drug

Laquinimod Appears Effective Against Multiple Sclerosis

0
Animal study indicates laquinimod slows disease progression, but human trials needed
Parkinson's disease patients with glucocerebrosidase gene mutations have increased risk for dementia and death

Dementia, Mortality Risk Up for GBA Carriers With Parkinson’s

0
Mortality risk remained greater in carriers after introduction of dementia as time-dependent covariate
An experimental DNA-based vaccine for Zika virus has proceeded to human safety trials

Animal Study Finds DNA-Based Vaccine Effective Against Zika

0
Human safety trials are already under way, researchers add
Falls are the leading cause of injury and death among older people in the United States

CDC: Falls Leading Cause of Injury, Death in U.S. Seniors

0
Falls cause millions of injuries and soaring health care costs, CDC report shows
For patients with type 1 diabetes

Decline in eGFR Mainly Linear in Type 1 Diabetes

0
Trajectories in eGRF decline were linear for about 87 percent of patients, accelerating for 6 percent